Page 36 - Covid19_Apr_30

SCIENCE & TECHNOLOGY EFFORTS ON COVID-19
BY
INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR) AND MINISTRY OF HEALTH & FAMILY WELFARE (MOHFW)
Call for proposals (CFP) forTranslational Immunology
Approaches to COVID-19
Indian Council of Medical Research (ICMR) invites full proposals (in ICMR Ad-hoc Project format) to fast-track the funding opportunities for Translational Immunology and Cellular Therapeutics approach targeting COVID-19 pandemic.All scientific institutions and laboratories are eligible to apply for this CFP.The supported projects are expected to start in June 2020 and should complete latest by the end of May 2022. Last date for project submission: 01 May 2020
Contact info: Dr Geeta Jotwani; tximmun.icmr@gmail.com
Website Link:
https://www.icmr.gov.in/pdf/covid/update/ICMR_COVID_19_Call_for_proposals_V1.pdf
Clinical trial of convalescent plasma in COVID-19 Patients
Clinical trial for convalescent plasma therapy is submitted by Indian Council of Medical Research (ICMR) on April 13, 2020 to Central Drugs Standard Control Organisation (CDSCO), India’s apex drug regulator body. CDSCO, on 17 April 2020, has approved the proposal of Indian Council for Medical Research (ICMR) for conducting clinical trial of convalescent plasma in Covid-19 patients, as per the protocol developed by the ICMR.
Website Link:
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?- num_id=NTg2Mw==
26